Swine flu ADR portal

on the 1 December 2009

The MHRA's special web-based system for reporting adverse reactions to swine flu medicines has been extended. The Swine Flu ADR Portal can now be used to notify the MHRA of adverse events following exposure to vaccines against H1N1 (Celvapan and Pandemrix) or seasonal flu, in addition to reporting adverse reactions to Tamiflu and Relenza.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

The most up-to-date drug information at your fingertips.

  • Get the prescribing support you need.
  • Register today for full access to the MIMS database, plus tables and guideline summaries, new and deleted products and consultation tools.
Register Now
Already Registered?

Forgotten password?

MIMS Clinics

Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.

More from MIMS

Live updates: Coronavirus (COVID-19) in the UK

Live updates: Coronavirus (COVID-19) in the UK

Use our timeline to follow the latest coronavirus developments...

NSAIDs safe in COVID-19, study confirms

NSAIDs safe in COVID-19, study confirms

Concerns were raised early in the COVID-19 pandemic...

Deleted products - live tracker

Deleted products - live tracker

EXCLUSIVE TO SUBSCRIBERS See the latest products removed...

New and deleted indications - live tracker

New and deleted indications - live tracker

EXCLUSIVE TO SUBSCRIBERS See the latest changes to...